PANCREAZE

AssetAlso called PANCREASE MT, pancrelipase

Provides pancreatic enzyme therapy.

Stage
Approved
Modality
Protein or enzyme
Target
Not known
1
Indication
0
Trials
1
Developer

Approved by the FDA on Apr 12, 2010 (BLA022523). FDA

Indications

1
  • Exocrine pancreatic insufficiency due to cystic fibrosis or other conditions

    Approved, vivus.com

In the full profile

  • Owner and partners1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets